Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiwei Chen

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
NPJ Vaccines|December 13, 2022
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccineJenny G Low, Ruklanthi de Alwis, Shiwei Chen, et al.
Nature Microbiology|October 4, 2022
SARS-CoV-2 Omicron variant emerged under immune selectionChee Wah Tan, Wan Ni Chia, Feng Zhu, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in miceRuklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
NPJ Vaccines|December 13, 2022
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccineJenny G Low, Ruklanthi de Alwis, Shiwei Chen, et al.
Nature Microbiology|October 4, 2022
SARS-CoV-2 Omicron variant emerged under immune selectionChee Wah Tan, Wan Ni Chia, Feng Zhu, et al.
Science Advances|July 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivorWan Ni Chia, Chee Wah Tan, Aaron Wai Kit Tan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in miceRuklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
Cell Reports|May 29, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gapsWan Ni Chia, Feng Zhu, Samuel Mo Sheng Cheng, et al.
Pageof 15